Meeder Advisory Services Inc. acquired a new position in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 2,208 shares of the company’s stock, valued at approximately $1,066,000.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Reflection Asset Management purchased a new position in shares of Astera Labs during the 4th quarter valued at $25,000. Smartleaf Asset Management LLC boosted its holdings in Astera Labs by 422.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after buying an additional 152 shares during the period. Towarzystwo Funduszy Inwestycyjnych PZU SA purchased a new stake in Astera Labs in the 4th quarter worth $33,000. Whipplewood Advisors LLC increased its stake in Astera Labs by 15,950.0% in the 1st quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock worth $35,000 after buying an additional 319 shares in the last quarter. Finally, Assetmark Inc. raised its holdings in Astera Labs by 78.9% during the fourth quarter. Assetmark Inc. now owns 229 shares of the company’s stock valued at $38,000 after acquiring an additional 101 shares during the period. 60.47% of the stock is currently owned by institutional investors.
Insider Transactions at Astera Labs
In other news, CEO Jitendra Mohan sold 90,630 shares of the company’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the sale, the chief executive officer directly owned 1,266,665 shares in the company, valued at approximately $431,109,432.75. This represents a 6.68% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Jack R. Lazar sold 10,000 shares of the stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the completion of the transaction, the director directly owned 75,688 shares of the company’s stock, valued at approximately $26,882,106.96. The trade was a 11.67% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 419,244 shares of company stock valued at $163,135,169 in the last 90 days. Company insiders own 10.40% of the company’s stock.
Astera Labs Stock Down 4.8%
Astera Labs (NASDAQ:ALAB – Get Free Report) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating the consensus estimate of $0.69 by $0.11. The business had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The business’s revenue was up 104.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, analysts anticipate that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.
Key Astera Labs News
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Analyst upgrade: Northland Securities raised Astera Labs to “Outperform,” supporting the bullish case for the stock. Northland Securities Upgrades Astera Labs to Outperform
- Positive Sentiment: AI connectivity demand: Coverage highlights record demand for Astera Labs’ connectivity products as AI data-center infrastructure expands. The company’s recent results reinforce that trend, with revenue up 104.5% year over year and earnings exceeding analyst expectations.
- Positive Sentiment: Strong growth profile: Astera Labs has posted accelerating quarterly revenue growth, while rising earnings estimates and demand for AI connectivity make it appear attractive relative to Broadcom in one comparison. ALAB vs. AVGO: Which AI Infrastructure Stock Is the Better Buy Now?
- Positive Sentiment: Platform expansion: Analysts argue Astera Labs is evolving beyond individual components into a broader AI-fabric platform, potentially increasing content per accelerator, customer stickiness and margins. Astera Labs: A Platform Getting Paid Like A Part
- Neutral Sentiment: Insider transactions: CEO Jitendra Mohan, COO Sanjay Gajendra and General Counsel Philip Mazzara sold shares worth roughly $64 million combined. The filings state the sales were made to cover tax withholding on vested equity awards, making them less concerning than discretionary sales, though they may still weigh on sentiment. SEC insider transaction filing
- Negative Sentiment: High valuation and volatility: With a price-to-earnings ratio above 140 and shares trading below their 50-day moving average, investors may be taking profits or reducing exposure despite strong fundamentals. The stock’s elevated beta also increases sensitivity to market and AI-sector sentiment.
Wall Street Analysts Forecast Growth
Several equities analysts have recently commented on ALAB shares. Roth Capital restated a “buy” rating and issued a $450.00 price objective on shares of Astera Labs in a research report on Wednesday, August 5th. Northland Securities upgraded Astera Labs from a “market perform” rating to an “outperform” rating and set a $350.00 target price for the company in a research report on Monday. Morgan Stanley lifted their target price on Astera Labs to $335.00 and gave the company an “overweight” rating in a research note on Monday, August 3rd. UBS Group reissued a “neutral” rating and issued a $425.00 price target on shares of Astera Labs in a report on Wednesday, August 5th. Finally, Susquehanna upped their price target on Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a research note on Friday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat, Astera Labs presently has a consensus rating of “Moderate Buy” and an average price target of $333.00.
Read Our Latest Stock Analysis on Astera Labs
Astera Labs Profile
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Featured Articles
- Five stocks we like better than Astera Labs
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
